Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Closed Posted
- Opportunity number
- PA-24-266
- Agency
-
Agency for Healthcare Research and Quality
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Non-501(c)(3) Nonprofits
- Tribal Governments (Federally Recognized)
- City/Township Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- Tribal Organizations (Not Federally Recognized)
- State Governments
- County Governments
- Special District Governments
- Other
- Independent School Districts
- 501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- Points of contact
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Agency for Healthcare Research and Quality (AHRQ), a division of the Department of Health and Human Services, is soliciting research applications that test promising digital healthcare interventions deployed at the point of care to improve healthcare service quality. This Notice of Funding Opportunity (NOFO PA-24-266) seeks projects that advance healthcare delivery systems through innovative digital solutions, with the application deadline set for March 25, 2026. Applicants must demonstrate scientific and technical merit, including qualified personnel capable of conducting rigorous research using appropriate methodology and budgeting. The evaluation process involves peer review by nonfederal experts in relevant scientific fields, with final selection decisions based on scientific merit, program alignment with AHRQ priorities, and fund availability. Key qualifications include institutional capacity to manage federal grants, compliance with federal audit requirements, and the ability to retain project records for a minimum of three years.
The R21/R33 Phased Innovation Award mechanism provides up to two years of R21 support for initial developmental activities followed by up to three years of R33 support for expanded activities, with typical award values ranging from $300,000 to $1,200,000 depending on project scope and complexity. Based on historical awards under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226), individual awards have ranged from approximately $44,000 to $4,000,000 for multi-year project periods. Research may be conducted across diverse healthcare delivery settings nationwide, including hospitals, ambulatory care practices, long-term care facilities, and integrated healthcare systems. Eligible applicants include higher education institutions, nonprofits, government agencies, tribal organizations, and other qualified organizations, with for-profit entities permitted only under cooperative agreement designations.
Synopsis
This NOFO invites applications that propose research projects that test promising digital healthcare interventions used at the point of care and aimed at improving the quality of healthcare services delivery. This NOFO will use the Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities, and up to 3 years of R33 support for expanded activities.
Files
| File | Type | Posted |
|---|---|---|
| PA-24-266-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity